全文获取类型
收费全文 | 184篇 |
免费 | 27篇 |
出版年
2022年 | 4篇 |
2021年 | 1篇 |
2020年 | 1篇 |
2019年 | 3篇 |
2018年 | 2篇 |
2017年 | 2篇 |
2016年 | 7篇 |
2015年 | 9篇 |
2014年 | 10篇 |
2013年 | 21篇 |
2012年 | 21篇 |
2011年 | 14篇 |
2010年 | 10篇 |
2009年 | 5篇 |
2008年 | 10篇 |
2007年 | 13篇 |
2006年 | 6篇 |
2005年 | 7篇 |
2004年 | 6篇 |
2003年 | 5篇 |
2002年 | 6篇 |
2001年 | 4篇 |
2000年 | 7篇 |
1999年 | 2篇 |
1998年 | 2篇 |
1997年 | 3篇 |
1996年 | 4篇 |
1995年 | 3篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1986年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1977年 | 3篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1970年 | 2篇 |
1962年 | 1篇 |
排序方式: 共有211条查询结果,搜索用时 421 毫秒
91.
This paper investigates the effectiveness of spiking agents when trained with reinforcement learning (RL) in a challenging multiagent task. In particular, it explores learning through reward-modulated spike-timing dependent plasticity (STDP) and compares it to reinforcement of stochastic synaptic transmission in the general-sum game of the Iterated Prisoner's Dilemma (IPD). More specifically, a computational model is developed where we implement two spiking neural networks as two "selfish" agents learning simultaneously but independently, competing in the IPD game. The purpose of our system (or collective) is to maximise its accumulated reward in the presence of reward-driven competing agents within the collective. This can only be achieved when the agents engage in a behaviour of mutual cooperation during the IPD. Previously, we successfully applied reinforcement of stochastic synaptic transmission to the IPD game. The current study utilises reward-modulated STDP with eligibility trace and results show that the system managed to exhibit the desired behaviour by establishing mutual cooperation between the agents. It is noted that the cooperative outcome was attained after a relatively short learning period which enhanced the accumulation of reward by the system. As in our previous implementation, the successful application of the learning algorithm to the IPD becomes possible only after we extended it with additional global reinforcement signals in order to enhance competition at the neuronal level. Moreover it is also shown that learning is enhanced (as indicated by an increased IPD cooperative outcome) through: (i) strong memory for each agent (regulated by a high eligibility trace time constant) and (ii) firing irregularity produced by equipping the agents' LIF neurons with a partial somatic reset mechanism. 相似文献
92.
Ornella J Rullo Jennifer MP Woo Miriam F Parsa Alice DC Hoftman Paul Maranian David A Elashoff Timothy B Niewold Jennifer M Grossman Bevra H Hahn Maureen McMahon Deborah K McCurdy Betty P Tsao 《Arthritis research & therapy》2013,15(1):R18
Introduction
Osteopontin (OPN) has been implicated as a mediator of Th17 regulation via type I interferon (IFN) receptor signaling and in macrophage activity at sites of tissue repair. This study assessed whether increased circulating plasma OPN (cOPN) precedes development of organ damage in pediatric systemic lupus erythematosus (pSLE) and compared it to circulating plasma neutrophil gelatinase-associated lipocalin (cNGAL), a predictor of increased SLE disease activity.Methods
cOPN and cNGAL were measured in prospectively followed pSLE (n = 42) and adult SLE (aSLE; n = 23) patients and age-matched controls. Time-adjusted cumulative disease activity and disease damage were respectively assessed using adjusted-mean SLE disease activity index (SLEDAI) (AMS) and SLICC/ACR damage index (SDI).Results
Compared to controls, elevated cOPN and cNGAL were observed in pSLE and aSLE. cNGAL preceded worsening SLEDAI by 3-6 months (P = 0.04), but was not associated with increased 6-month AMS. High baseline cOPN, which was associated with high IFNalpha activity and expression of autoantibodies to nucleic acids, positively correlated with 6-month AMS (r = 0.51 and 0.52, P = 0.001 and 0.01 in pSLE and aSLE, respectively) and was associated with SDI increase at 12 months in pSLE (P = 0.001). Risk factors for change in SDI in pSLE were cOPN (OR 7.5, 95% CI [2.9-20], P = 0.03), but not cNGAL, cumulative prednisone, disease duration, immunosuppression use, gender or ancestry using univariate and multivariate logistic regression. The area under the curve (AUC) when generating the receiver-operating characteristic (ROC) of baseline cOPN sensitivity and specificity for the indication of SLE patients with an increase of SDI over a 12 month period is 0.543 (95% CI 0.347-0.738; positive predictive value 95% and negative predictive value 38%).Conclusion
High circulating OPN levels preceded increased cumulative disease activity and organ damage in SLE patients, especially in pSLE, and its value as a predictor of poor outcome should be further validated in large longitudinal cohorts. 相似文献93.
Chris Christodoulou Sudhir Agrawal Michael J. Gait 《Nucleosides, nucleotides & nucleic acids》2013,32(1-2):341-344
Abstract The 2-(2,4-dinitrobenzenesulphenyloxymethyl)benzoyl (DNBSB) group is proposed as a protecting group for the 5′-position of nucleosides. The DNBSB group may be removed under mild non-acidic conditions and may have potential in solid-phase synthesis of oligoribo- and oligodeoxyribonucleotides. 相似文献
94.
George Pentheroudakis Vassiliki Kotoula Anastasia G. Eleftheraki Eleftheria Tsolaki Ralph M. Wirtz Konstantine T. Kalogeras Anna Batistatou Mattheos Bobos Meletios A. Dimopoulos Eleni Timotheadou Helen Gogas Christos Christodoulou Kyriaki Papadopoulou Ioannis Efstratiou Chrisoula D. Scopa Irene Papaspyrou Dimitrios Vlachodimitropoulos Helena Linardou Epaminontas Samantas Dimitrios Pectasides Nicholas Pavlidis George Fountzilas 《PloS one》2013,8(7)
Background
Discrepant data have been published on the incidence and prognostic significance of ESR1 gene amplification in early breast cancer.Patients and Methods
Formalin-fixed paraffin-embedded tumor blocks were collected from women with early breast cancer participating in two HeCOG adjuvant trials. Messenger RNA was studied by quantitative PCR, ER protein expression was centrally assessed using immunohistochemistry (IHC) and ESR1 gene copy number by dual fluorescent in situ hybridization probes.Results
In a total of 1010 women with resected node-positive early breast adenocarcinoma, the tumoral ESR1/CEP6 gene ratio was suggestive of deletion in 159 (15.7%), gene gain in 551 (54.6%) and amplification in 42 cases (4.2%), with only 30 tumors (3%) harboring five or more ESR1 copies. Gene copy number ratio showed a significant, though weak correlation to mRNA and protein expression (Spearman''s Rho <0.23, p = 0.01). ESR1 clusters were observed in 9.5% (57 gain, 38 amplification) of cases. In contrast to mRNA and protein expression, which were favorable prognosticators, gene copy number changes did not obtain prognostic significance. When ESR1/CEP6 gene ratio was combined with function (as defined by ER protein and mRNA expression) in a molecular classifier, the Gene Functional profile, it was functional status that impacted on prognosis. In univariate analysis, patients with functional tumors (positive ER protein expression and gene ratio normal or gain/amplification) fared better than those with non-functional tumors with ESR1 gain (HR for relapse or death 0.49–0.64, p = 0.003). Significant interactions were observed between gene gain/amplification and paclitaxel therapy (trend for DFS benefit from paclitaxel only in patients with ESR1 gain/amplification, p = 0.066) and Gene Functional profile with HER2 amplification (Gene Functional profile prognostic only in HER2-normal cases, p = 0.029).Conclusions
ESR1 gene deletion and amplification do not constitute per se prognostic markers, instead they can be classified to distinct prognostic groups according to their protein-mediated functional status. 相似文献95.
Michael S. Christodoulou Alessandro Sacchetti Valentina Ronchetti Stefania Caufin Alessandra Silvani Giordano Lesma Gabriele Fontana Fabrizio Minicone Benedetta Riva Micol Ventura Maija Lahtela-Kakkonen Elina Jarho Valentina Zuco Franco Zunino Nadine Martinet Federico Dapiaggi Stefano Pieraccini Maurizio Sironi Daniele Passarella 《Bioorganic & medicinal chemistry》2013,21(22):6920-6928
This paper reports the synthesis of a series of evodiamine derivatives. We assayed the ability to inhibit cell growth on three human tumour cell lines (H460, MCF-7 and HepG2) and we evaluated the capacity to interfere with the catalytic activity of topoisomerase I both by the relaxation assay and the occurrence of the cleavable complex. Moreover, whose effect on sirtuins 1, 2 and 3 was investigated. Finally, molecular docking analyses were performed in an attempt to rationalize the biological results. 相似文献
96.
Heidebrecht T Christodoulou E Chalmers MJ Jan S Ter Riet B Grover RK Joosten RP Littler D van Luenen H Griffin PR Wentworth P Borst P Perrakis A 《Nucleic acids research》2011,39(13):5715-5728
The J-binding protein 1 (JBP1) is essential for biosynthesis and maintenance of DNA base-J (β-d-glucosyl-hydroxymethyluracil). Base-J and JBP1 are confined to some pathogenic protozoa and are absent from higher eukaryotes, prokaryotes and viruses. We show that JBP1 recognizes J-containing DNA (J-DNA) through a 160-residue domain, DB-JBP1, with 10 000-fold preference over normal DNA. The crystal structure of DB-JBP1 revealed a helix-turn-helix variant fold, a ‘helical bouquet’ with a ‘ribbon’ helix encompassing the amino acids responsible for DNA binding. Mutation of a single residue (Asp525) in the ribbon helix abrogates specificity toward J-DNA. The same mutation renders JBP1 unable to rescue the targeted deletion of endogenous JBP1 genes in Leishmania and changes its distribution in the nucleus. Based on mutational analysis and hydrogen/deuterium-exchange mass-spectrometry data, a model of JBP1 bound to J-DNA was constructed and validated by small-angle X-ray scattering data. Our results open new possibilities for targeted prevention of J-DNA recognition as a therapeutic intervention for parasitic diseases. 相似文献
97.
David K. Miller Minal J. Menezes Cas Simons Lisa G. Riley Sandra T. Cooper Sean M. Grimmond David R. Thorburn John Christodoulou Ryan J. Taft 《PloS one》2014,9(8)
Leigh syndrome (LS) is a rare progressive multi-system neurodegenerative disorder, the genetics of which is frequently difficult to resolve. Rapid determination of the genetic etiology of LS in a 5-year-old girl facilitated inclusion in Edison Pharmaceutical’s phase 2B clinical trial of EPI-743. SNP-arrays and high-coverage whole exome sequencing were performed on the proband, both parents and three unaffected siblings. Subsequent multi-tissue targeted high-depth mitochondrial sequencing was performed using custom long-range PCR amplicons. Tissue-specific mutant load was also assessed by qPCR. Complex I was interrogated by spectrophotometric enzyme assays and Western Blot. No putatively causal mutations were identified in nuclear-encoded genes. Analysis of low-coverage off-target mitochondrial reads revealed a previously unreported mitochondrial mutation in the proband in MT-ND3 (m.10134C>A, p.Q26K), a Complex I mitochondrial gene previously associated with LS. Targeted investigations demonstrated that this mutation was 1% heteroplasmic in the mother’s blood and homoplasmic in the proband’s blood, fibroblasts, liver and muscle. Enzyme assays revealed decreased Complex I activity. The identification of this novel LS MT-ND3 variant, the genomics of which was accomplished in less than 3.5 weeks, indicates that rapid genomic approaches may prove useful in time-sensitive cases with an unresolved genetic diagnosis. 相似文献
98.
99.
Recent advances allow multiplexed genome engineering in E. coli, employing easily designed oligonucleotides to edit multiple loci simultaneously. A similar technology in human cells would greatly expedite functional genomics, both by enhancing our ability to test how individual variants such as single nucleotide polymorphisms (SNPs) are related to specific phenotypes, and potentially allowing simultaneous mutation of multiple loci. However, oligo-mediated targeting of human cells is currently limited by low targeting efficiencies and low survival of modified cells. Using a HeLa-based EGFP-rescue reporter system we show that use of modified base analogs can increase targeting efficiency, in part by avoiding the mismatch repair machinery. We investigate the effects of oligonucleotide toxicity and find a strong correlation between the number of phosphorothioate bonds and toxicity. Stably EGFP-corrected cells were generated at a frequency of ~0.05% with an optimized oligonucleotide design combining modified bases and reduced number of phosphorothioate bonds. We provide evidence from comparative RNA-seq analysis suggesting cellular immunity induced by the oligonucleotides might contribute to the low viability of oligo-corrected cells. Further optimization of this method should allow rapid and scalable genome engineering in human cells. 相似文献
100.